Results 141 to 150 of about 3,735,339 (297)

Antibiotic resistance in Acinetobacter species in nosocomial and outpatient infections

open access: yes, 1998
Purpose: Acinetobacter spp. are the second most frequently isolated non-fermenter in the hospital environment after Pseudomonas aeruginosa and may cause a variety of infections.
Yaman A., Aksungur P.
core  

Prevalence of Extended-spectrum Beta-lactamase (ESBL), Metallo Beta-lactamase (MBL) and Carbapenemase Producing Acinetobacter Species Isolated from Various Clinical Samples in Tertiary Care Hospital

open access: yesJournal of Pure and Applied Microbiology
Acinetobacter is an important nosocomial pathogen causing health care associated infections. It is highly antibiotic resistant gram-negative bacilli. The study was done to determine the prevalence of Acinetobacter species isolated from various clinical ...
Manasi Vikas Yadav   +4 more
doaj   +1 more source

Periodontitis and Inflammatory Bowel Diseases: Mechanistic Evidence

open access: yesJournal of Periodontal Research, EarlyView.
This review aims to provide a conceptual framework for understanding the mechanistic interplay between periodontitis and IBD, with a particular emphasis on the microbial and immunological crosstalk linking the oral cavity and the gastrointestinal tract.
Ana Paula V. Colombo   +3 more
wiley   +1 more source

Acinetobacter bacteraemia in Thailand: evidence for infections outside the hospital setting

open access: yes, 2014
Acinetobacter is a well-recognized nosocomial pathogen. Previous reports of community-associated Acinetobacter infections have lacked clear case definitions and assessment of healthcare-associated (HCA) risk factors.
PERUSKI, L. F.   +14 more
core   +1 more source

Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges

open access: yesClinical Microbiology Reviews, 2016
D. Wong   +5 more
semanticscholar   +1 more source

Nitric Oxide Tunes Secreted Metabolite Bioactivity

open access: yesMolecular Microbiology, EarlyView.
Pseudomonas aeruginosa produces phenazine metabolites that can react with nitric oxide (·NO) to form nitrosylated compounds. The formation of these metabolites results in rapid loss in P. aeruginosa viability and diminishes phenazine antimicrobial activity against other organisms, including Staphylococcus aureus. ABSTRACT The radical nitric oxide (·NO)
Zachery R. Lonergan   +7 more
wiley   +1 more source

Acinetobacter baumannii: an evolving and cunning opponent

open access: yesFrontiers in Microbiology
Acinetobacter baumannii is one of the most common multidrug-resistant pathogens causing nosocomial infections. The prevalence of multidrug-resistant A. baumannii infections is increasing because of several factors, including unregulated antibiotic use. A.
Jingchao Shi   +4 more
semanticscholar   +1 more source

Oral Microbiome in Systemic Autoimmune Diseases: A Systematic Review

open access: yesOral Diseases, EarlyView.
ABSTRACT Objective The oral cavity represents a key but underexplored interface between host immunity and microbial communities. The aim of this systematic review was to synthesize current literature on oral microbiota alterations in systemic autoimmune diseases.
Sophie Jung   +2 more
wiley   +1 more source

The effects of far‐UVC irradiation on the presence and concentration of ESKAPEE pathogens on hospital surfaces: Study protocol for a multi‐site, double‐blinded randomized controlled trial in La Paz, Bolivia

open access: yesPhotochemistry and Photobiology, EarlyView.
The protocol of a multi‐site, double‐blinded, clustered randomized controlled trial (cRCT) with a binary outcome of the presence of viable presumptive ESKAPEE pathogens on surfaces in and around hospital sinks is to be implemented in two Bolivian hospitals.
Lindsay B. Saber   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy